Intra-individual variability of residual platelet reactivity assessed by the VerifyNow-P2Y12 assay in patients with clopidogrel resistance after percutaneous coronary intervention

Platelets. 2011;22(4):305-7. doi: 10.3109/09537104.2010.525268. Epub 2011 Apr 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aged
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Clopidogrel
  • Coronary Artery Disease* / diagnosis
  • Coronary Artery Disease* / drug therapy
  • Coronary Artery Disease* / surgery
  • Drug Resistance / physiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / pharmacology
  • Platelet Aggregation Inhibitors / therapeutic use
  • Platelet Function Tests
  • Purinergic P2Y Receptor Antagonists / pharmacology
  • Purinergic P2Y Receptor Antagonists / therapeutic use
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / pharmacology
  • Ticlopidine / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Clopidogrel
  • Ticlopidine